Skip to main content
Clinical Trials/RBR-3h2gv8r
RBR-3h2gv8r
Recruiting
N/A

Contrast-Induced Nephropathy: evaluation of preventive measures, based on serum levels of Creatinine and Cystatin C, in patients with Moderate and Severe Chronic Kidney Disease

Hospital Geral de Goiania dr Alberto Rassi0 sitesMarch 31, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Hospital Geral de Goiania dr Alberto Rassi
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 31, 2023
End Date
December 31, 2023
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
Hospital Geral de Goiania dr Alberto Rassi

Eligibility Criteria

Inclusion Criteria

  • Patients hospitalized due to peripheral obstructive arterial disease requiring
  • contrast tests (diagnostic and/or therapeutic arteriographies only); Completion of the Free and Informed Consent Form (FICT); Patients with normal renal function (GFR greater than 60 ml/min/1\.73m2\) to compose the control group; Patients with changes in renal function compatible with moderate chronic kidney disease (GFR between 30\-59 ml/min/1\.73m2\) or severe chronic kidney disease (GFR less than 30 ml/min/1\.73m2\)

Exclusion Criteria

  • Patients with: congestive heart failure, septic or cardiogenic shock; Patients who used nephrotoxic medications or iodinated contrast in the 48\-hour period before the evaluation; Patients with acute kidney injury or chronic kidney disease on dialysis

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
Can increased urine flow encouraged by the drug furosemide and increased water intake prevent kidney injury caused by the contrast media used in angiography procedures in patients with reduced kidney function?Prevention of contrast-induced nephropathy in patients with impaired renal function undergoing percutaneous coronary interventions for chronic total occlusion of the coronary arteriesUrological and Genital Diseases
ISRCTN72194653niversity of Sulaimani College of Medicine998
Unknown
N/A
Acute kidney injury in patients treated for symptomatic peripheral arterial diseasePAD:Peripheral artery diseaseCRI:Chronic renal insufficiencyIC:Intermittent claudicationCLI:Critical limb ischemiaGFR: Glomerular filtration ratePTA:Percutaneous transluminal angioplastyCIN:Contrast induced nephropathyPCI:Percutaneous coronary interventionCKD:Chronic kidney disease
NL-OMON26709T.A. Sigterman MD, Resident general surgeryDepartment of SurgeryAtrium Medical CentreHenri Dunantstraat 56419PC Heerlen Email: timsigterman@gmail.com350
Not Yet Recruiting
N/A
Renal dysfunction in patients undergoing primary PCI for acute myocardial infraction.
CTRI/2018/06/014495Kasturba medical college and hospital
Not Yet Recruiting
N/A
Protection from Contrast Induced Nephropathy with Remote Ischemic ConditioningSubjects with CKD (eGFR &lt60ml/min/m2) undergoing elective CAG and PCI
JPRN-UMIN000011264Osaka City University270
Completed
N/A
Study on contrast-induced nephropathy preventive effect of remote preconditioning in elective PCI patientsCKD inhospital patients(eGFR&lt60ml/min/m2) undergoing elective PCI
JPRN-UMIN000010751Osaka General Medical Center180